Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 14/20 | 0.51 |
| ▸ | AKT2 | P31751 | 5/20 | 0.51 |
| ▸ | AKT3 | Q9Y243 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL804796 | 0.94 | AKT1 (0.47) | AKT1AKT2AKT3MEN1KMT2A | |
| SCHEMBL804813 | 0.92 | AKT1 (0.58) | AKT1AKT2AKT3MEN1KMT2A | |
| SCHEMBL13943550 | 0.88 | TSHR (0.52) | AKT1AKT2AKT3MEN1KMT2A | |
| SCHEMBL13052968 | 0.87 | AKT1 (0.48) | AKT1AKT2AKT3MEN1KMT2A | |
| SCHEMBL13943559 | 0.86 | RECQL (0.52) | AKT1AKT2AKT3 | |
| SCHEMBL12854007 | 0.84 | AKT1 (0.51) | AKT1AKT2AKT3MEN1KMT2A | |
| SCHEMBL13053163 | 0.84 | AKT1 (0.50) | AKT1AKT2AKT3MEN1KMT2A | |
| SCHEMBL12661336 | 0.83 | MEN1 (0.50) | AKT1AKT2AKT3MEN1KMT2A | |
| SCHEMBL16139466 | 0.82 | ALDH1A1 (0.46) | AKT1AKT2AKT3MEN1KMT2A | |
| SCHEMBL13052969 | 0.82 | AKT1 (0.59) | AKT1AKT2AKT3MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090085469-A1 | LUMINESCENT METAL COMPLEX, METHOD FOR PRODUCING SAME AND ORGANIC ELECTROLUMINESCENT LIGHT-EMITTING DEVICE USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2009-04-02 | — | — | US | disclosed |
| US-20090085469-A1 | LUMINESCENT METAL COMPLEX, METHOD FOR PRODUCING SAME AND ORGANIC ELECTROLUMINESCENT LIGHT-EMITTING DEVICE USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2009-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090085469-A1 | LUMINESCENT METAL COMPLEX, METHOD FOR PRODUCING SAME AND ORGANIC ELECTROLUMINESCENT LIGHT-EMITTING DEVICE USING SAME | EMC2, SOD1, ICOSLG | AKT1 4410/4885AKT2 4739/4885AKT3 4813/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.